The call ran from 10:01 AM to 10:58 AM IST (58 min).
Key takeaways
KIMS delivered strong revenue growth led by Kondapur's rapid ramp-up, despite temporary margin compression from new oncology programs.
| Revenue growth | 41.3% YoY to ₹1,363 Cr, driven by Kondapur expansion. |
|---|---|
| Margins | Temporary dip due to new programs; long-term 25-30% target maintained. |
| Demand visibility | Strong IP/OP volumes indicate robust demand in core clusters. |
| Management confidence | High, emphasizing aggressive expansion and efficient hospital ramp-ups. |
Growth
Consolidated revenue grew 41.3% YoY to ₹1,363 Cr, driven by volume and ARP growth.
Outlook
Expects 30% EBITDA margins at Kondapur and ₹1,100 Cr capex over next 18 months.
Risks
High fixed costs in expansion units and potential regulatory impact on anti-cancer drug margins.
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.6 Cr · +3.6% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
Management targets 1.25x revenue on ₹100 crore capex with 20-25% EBITDA within 3-5 years post-maturation.
Growth they described
Revenue growth is volume-led with 25% contribution from high-margin COVID-related cases and insurance/cash mix.
Call details
| Company | Krishna Institute Of Medical Sciences Ltd |
|---|---|
| NSE symbol | KIMS |
| ISIN | INE967H01025 |
| Call | Q2 FY27 earnings call |
| Date | Thursday, 5 November 2026 |
| Time | 10:00 AM IST |
| Length | 58 min |
| Audio | Our stream on YouTube ↗ |
Krishna Institute Of Medical Sciences Ltd: key numbers
- Share price
- ₹740.55
- Market cap
- ₹31,104 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 146.4×Sector 54.5×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Thu, 5 Nov
Today's concalls →
